Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SHP-1 is a protein tyrosine phosphatase that acts as a negative regulator in multiple signaling pathways within hematopoietic cells, dephosphorylating phospho-proteins involved in immune cell signaling. It functions as a tumor suppressor during tumor progression due to its ability to inhibit pro-oncogenic signals like STAT3 activation. Mutations or altered expression patterns are associated with autoimmune diseases and various cancers.
Activation of SHP-1 phosphatase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Tyrosine Phosphatase Non-Receptor Type 6 (SHP-1).